Stephen Huhn
Technik-/Wissenschafts-/F&E-Leiter bei CONTINEUM THERAPEUTICS, INC.
Vermögen: - $ am 31.05.2024
Profil
Stephen L.
Huhn is currently the Chief Medical Officer & SVP-Clinical Development at Contineum Therapeutics, Inc. He previously worked as an Associate Professor-Neurosurgery at Stanford University.
From 2015 to 2016, he served as the Chief Medical Officer & VP-Clinical Research at StemCells, Inc. Dr. Huhn obtained his doctorate degree from the University of Arizona in 1987.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 24.05.2024 | 0 ( -.--% ) | - $ | 31.05.2024 |
Aktive Positionen von Stephen Huhn
| Unternehmen | Position | Beginn |
|---|---|---|
| CONTINEUM THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2020 |
Ehemalige bekannte Positionen von Stephen Huhn
| Unternehmen | Position | Ende |
|---|---|---|
StemCells, Inc.
 StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2016 |
| Stanford University | Corporate Officer/Principal | - |
Ausbildung von Stephen Huhn
| University of Arizona | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CONTINEUM THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | Health Technology |
